Medicare Enrolled
Dr. Magali Van Den Bergh, M.D.
Hematology · Fort Myers, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Van Den Bergh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Van Den Bergh? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Van Den Bergh
Dr. Magali Van Den Bergh is a hematology in Fort Myers, FL, with 13 years in practice. Based on federal Medicare data, Dr. Van Den Bergh performed 157,784 Medicare services across 4,434 unique beneficiaries.
Between the years covered by Open Payments, Dr. Van Den Bergh received a total of $24,896 from 86 pharmaceutical and/or device companies across 795 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Van Den Bergh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 33% volume in FL$ $24,896 industry payments
Medicare Practice Summary
Medicare Utilization ↗157,784
Medicare services
Top 33% in FL for hematology
4,434
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12,137 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 25,200 | $43 | $137 |
| Azacitidine chemotherapy injection | 15,900 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 15,470 | $1 | $5 |
| Iron infusion (Feraheme) | 15,300 | $0 | $4 |
| Iron sucrose injection (Venofer) | 13,000 | $0 | $5 |
| Daratumumab injection (Darzalex) | 12,780 | $38 | $110 |
| Filgrastim injection (Zarxio) for white blood cells | 12,540 | $0 | $2 |
| Paclitaxel chemotherapy injection | 9,490 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 7,800 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 7,080 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 3,496 | $36 | $108 |
| Dexamethasone injection (steroid) | 3,179 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,139 | $8 | $29 |
| Blood draw (venipuncture) | 1,926 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,920 | $1 | $28 |
| Injection, atropine sulfate, 0.01 mg | 1,880 | $0 | $1 |
| Office visit, established patient (30-39 min) | 1,130 | $98 | $339 |
| Injection, leucovorin calcium, per 50 mg | 823 | $3 | $12 |
| Injection of additional new drug or substance into vein | 777 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 732 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 634 | $103 | $378 |
| Drug injection, under skin or into muscle | 605 | $11 | $69 |
| Injection, fluorouracil, 500 mg | 548 | $2 | $7 |
| Injection, carboplatin, 50 mg | 439 | $2 | $41 |
| Injection, diphenhydramine hcl, up to 50 mg | 228 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 226 | $49 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 196 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 192 | $52 | $178 |
| Administration of chemotherapy into vein, each additional hour | 164 | $23 | $79 |
| Office visit, established patient, complex (40-54 min) | 160 | $144 | $474 |
| Injection, zoledronic acid, 1 mg | 160 | $7 | $69 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 155 | $58 | $206 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 150 | $23 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 148 | $16 | $56 |
| Infusion into a vein for hydration, each additional hour | 133 | $10 | $42 |
| Infusion, normal saline solution , 1000 cc | 127 | $2 | $7 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 121 | $18 | $59 |
| Red blood count, automated test | 92 | $4 | $10 |
| Infusion into a vein for hydration, 31-60 minutes | 86 | $26 | $156 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 68 | $134 | $637 |
| Injection of drug or substance into vein | 67 | $29 | $156 |
| Office visit, established patient (20-29 min) | 65 | $65 | $239 |
| New patient office visit (45-59 min) | 63 | $126 | $453 |
| New patient office visit, complex (60-74 min) | 62 | $174 | $585 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 56 | $16 | $56 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 55 | $26 | $89 |
| Automated urinalysis | 45 | $2 | $8 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 39 | $1 | $7 |
| Administration of additional new drug or substance into vein using push technique | 34 | $43 | $170 |
| Drawing of blood for a medical problem | 32 | $68 | $277 |
| Hospital follow-up visit, moderate complexity | 21 | $65 | $197 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 21 | $3 | $11 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 19 | $4 | $15 |
| Initial hospital admission, moderate complexity | 11 | $107 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.6% high complexity
83.6% medium
3.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,896
Total received (2018-2024)
Avg $3,557/year across 7 years
Top 19% in FL for hematology
86
Companies
795
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,944 (56.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,701 (43.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$252 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,277
2023$4,727
2022$3,117
2021$9,219
2020$2,703
2019$1,517
2018$336
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MorphoSys, US Inc.
$4,378
JAZZ PHARMACEUTICALS INC.
$2,122
SERVIER PHARMACEUTICALS LLC
$1,680
Seagen Inc.
$1,658
E.R. Squibb & Sons, L.L.C.
$1,311
Merck Sharp & Dohme LLC
$1,021
Adaptive Biotechnologies Corporation
$1,000
PFIZER INC.
$984
Celgene Corporation
$894
BeiGene USA, Inc.
$755
Novartis Pharmaceuticals Corporation
$723
Janssen Biotech, Inc.
$714
Incyte Corporation
$622
Merck Sharp & Dohme Corporation
$472
Lilly USA, LLC
$433
GENZYME CORPORATION
$377
Daiichi Sankyo Inc.
$365
Gilead Sciences, Inc.
$307
Astellas Pharma US Inc
$302
GlaxoSmithKline, LLC.
$271
ARRAY BIOPHARMA INC
$269
Takeda Pharmaceuticals U.S.A., Inc.
$231
TAIHO ONCOLOGY, INC.
$204
Regeneron Healthcare Solutions, Inc.
$200
Exelixis Inc.
$197
Amgen Inc.
$187
Eisai Inc.
$181
Pharmacyclics LLC, An AbbVie Company
$180
AstraZeneca Pharmaceuticals LP
$159
Alexion Pharmaceuticals, Inc.
$148
Genentech USA, Inc.
$126
Bayer HealthCare Pharmaceuticals Inc.
$109
Seattle Genetics, Inc.
$94
ABBVIE INC.
$94
Pharmacosmos Therapeutics Inc.
$87
Mirati Therapeutics, Inc.
$86
Spectrum Pharmaceuticals Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
EMD Serono, Inc.
$75
Genmab U.S., Inc.
$74
Bayer Healthcare Pharmaceuticals Inc.
$71
Alnylam Pharmaceuticals Inc.
$67
Kite Pharma, Inc.
$67
GE HEALTHCARE
$65
EISAI INC.
$65
SOBI, INC
$62
Rigel Pharmaceuticals, Inc.
$59
PharmaEssentia USA Corporation
$59
ADC Therapeutics America, Inc.
$57
SpringWorks Therapeutics, Inc.
$56
Sobi, Inc
$51
Fennec Pharmaceuticals, Inc.
$51
Deciphera Pharmaceuticals Inc.
$50
CTI BioPharma Corp.
$49
Foundation Medicine, Inc.
$48
NanoString Technologies, Inc.
$48
Helsinn Therapeutics (U.S.), Inc.
$47
PUMA BIOTECHNOLOGY, INC.
$45
Sun Pharmaceutical Industries Inc.
$45
Agios Pharmaceuticals, Inc.
$44
Puma Biotechnology, Inc.
$40
Stemline Therapeutics Inc.
$33
Karyopharm Therapeutics Inc.
$31
TerSera Therapeutics LLC
$31
Acrotech Biopharma LLC
$30
Myovant Sciences Inc.
$29
Jazz Pharmaceuticals Inc.
$29
Clinigen Inc
$26
AbbVie, Inc.
$24
Novo Nordisk Inc
$21
Aurobindo Pharma USA, Inc.
$19
Clovis Oncology, Inc.
$19
Epizyme, Inc.,
$19
Ipsen Biopharmaceuticals, Inc
$18
Tempus AI, Inc
$17
Cumberland Pharmaceuticals, Inc.
$17
TESARO, Inc.
$16
GE HealthCare
$16
Tactile Systems Technology Inc
$16
Medtronic, Inc.
$16
Sumitomo Pharma America, Inc.
$14
Dendreon Pharmaceuticals LLC
$14
Dova Pharmaceuticals
$14
Veracyte, Inc.
$13
Sirtex Medical Inc
$12
Heron Therapeutics, Inc.
$10
Top 3 companies account for 32.9% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · Alecensa · Aliqopa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · Erleada · Esperoct · FOUNDATIONONE · FRUZAQLA · Fabhalta · Flexitouch Plus · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Pedmark · Phesgo · Pomalyst · Proleukin · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · Sustol · TABRECTA · TASIGNA · TAZVERIK · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Venclexta · Vonjo · Vyloy · XALKORI · XPOVIO · XTANDI · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $16 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
17
Per 100K population
2.1
County median income
$73,099
Nearest hospital
GULF COAST MEDICAL CENTER LEE HEALTH
8.1 mi
8.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Van Den Bergh is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 19%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Van Den Bergh experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Van Den Bergh performed 25,200 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Van Den Bergh receive payments from pharmaceutical companies?
Yes. Dr. Van Den Bergh received a total of $24,896 from 86 companies across 795 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Van Den Bergh's costs compare to other hematologys in Fort Myers?
Dr. Van Den Bergh's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Van Den Bergh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Fort Myers
Browse hematologys in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
MorphoSys, US Inc. Payments to Doctors
See all physicians who received payments from MorphoSys, US Inc..
By company
JAZZ PHARMACEUTICALS INC. Payments to Doctors
See all physicians who received payments from JAZZ PHARMACEUTICALS INC..
By company
SERVIER PHARMACEUTICALS LLC Payments to Doctors
See all physicians who received payments from SERVIER PHARMACEUTICALS LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology